These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 33726009)

  • 1. Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report.
    Huang Z; Xie J
    Medicine (Baltimore); 2021 Mar; 100(11):e25188. PubMed ID: 33726009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe Infection.
    Liang J; Xu X; Chen Z; Yu J; Tang Y
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e360-e362. PubMed ID: 38691058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
    Yan WL; Yang SL; Zhao FY; Xu XJ
    J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ruxolitinib combined with liposomal doxorubicin, etoposide, methylprednisolone+/-PEG-asparaginase in treatment of relapsed/refractory pediatric hemophagocytic lymphohistiocytosis].
    Wei A; Ma HH; Zhang LP; Lian HY; Du JY; Wang D; Cui L; Ou WX; Zhao YZ; Zhao XX; Zhang L; Li ZG; Wang TY; Zhang R
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2167-2172. PubMed ID: 35872580
    [No Abstract]   [Full Text] [Related]  

  • 5. Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale.
    Trantham T; Auten J; Muluneh B; Van Deventer H
    J Oncol Pharm Pract; 2020 Jun; 26(4):1005-1008. PubMed ID: 31575356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report.
    Mărginean MO; Molnar E; Chinceşan MI
    Medicine (Baltimore); 2020 Jan; 99(3):e18759. PubMed ID: 32011461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus.
    Ueda T; Itabashi T; Yamanishi S; Tanabe Y; Migita M; Itoh Y
    J Nippon Med Sch; 2020 Jul; 87(3):166-170. PubMed ID: 32238729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
    Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
    Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children.
    Wei A; Ma H; Li Z; Zhang L; Zhang Q; Wang D; Lian H; Zhang R; Wang T
    Int J Hematol; 2020 Oct; 112(4):568-576. PubMed ID: 32666469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis.
    Zhang Q; Zhao YZ; Ma HH; Wang D; Cui L; Li WJ; Wei A; Wang CJ; Wang TY; Li ZG; Zhang R
    Blood; 2022 Jun; 139(24):3493-3504. PubMed ID: 35344583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis.
    Zhang Q; Wei A; Ma HH; Zhang L; Lian HY; Wang D; Zhao YZ; Cui L; Li WJ; Yang Y; Wang TY; Li ZG; Zhang R
    Haematologica; 2021 Jul; 106(7):1892-1901. PubMed ID: 32732367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis.
    Sathiyamoorthy S; Shad A; Ozdemirli M
    Pediatr Blood Cancer; 2011 May; 56(5):850-2. PubMed ID: 21370422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
    Lee JS; Kang JH; Lee GK; Park HJ
    J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy.
    Chikagawa Y; Hikishima K; Mizumaki H; Sugimori C; Nakagishi Y; Yachie A; Nakao S
    Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
    J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
    Matsuo Y; Iwanami K; Hiraoka E; Oda R
    Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
    Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K
    Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [L-DEP regimen salvage therapy for refractory primary hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection in 4 children].
    Zhao YZ; Ma HH; Lian HY; Wang D; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2024 May; 62(5):467-472. PubMed ID: 38623016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 47.